UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mountains of evidence: The effects of abnormal air pollution on crime

Journal of economic behavior & organization, 2023-06, Vol.210, p.288-319

2023

Volltextzugriff (PDF)

Capivasertib: A Novel AKT Inhibitor Approved for Hormone-Receptor-Positive, HER-2-Negative Metastatic Breast Cancer

The Annals of pharmacotherapy, 2024-04

2024

Volltextzugriff (PDF)

Antiangiogenic Therapy for Cancer: An Update

Pharmacotherapy, 2012-12, Vol.32 (12), p.1095-1111

2012

Volltextzugriff (PDF)

Nilotinib: A second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia

Clinical therapeutics, 2008-11, Vol.30 (11), p.1956-1975

2008

Volltextzugriff (PDF)

Lack of adequate pneumococcal vaccination response in chronic lymphocytic leukaemia patients receiving ibrutinib

British journal of haematology, 2018-09, Vol.182 (5), p.712-714

2018

Volltextzugriff (PDF)

Evaluating Treatment Options and the Multidisciplinary Care of Ocular Toxicities of MEK Inhibitors

Oncology (Williston Park, N.Y.), 2023-03, Vol.37 (3), p.138-139

2023

Volltextzugriff (PDF)

Tyrosine kinase inhibitors in the treatment of systemic mastocytosis

Leukemia research, 2011-09, Vol.35 (9), p.1143-1152

2011

Volltextzugriff (PDF)

Suspiciously timed trade disputes

Journal of international economics, 2017-03, Vol.105, p.57-76

2017

Volltextzugriff (PDF)

Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies

Cancer epidemiology, biomarkers & prevention, 2023-12, Vol.32 (12), p.1675-1682

2023

Volltextzugriff (PDF)

Emergence of ocular toxicities associated with novel anticancer therapeutics: What the oncologist needs to know

Cancer treatment reviews, 2022-04, Vol.105, p.102376-102376, Article 102376

2022

Volltextzugriff (PDF)

Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline-Based Chemotherapy

Journal of the American Heart Association, 2023-05, Vol.12 (10), p.e027981-e027981

2023

Volltextzugriff (PDF)

The Emerging Role of PD-1/PD-L1–Targeting Immunotherapy in the Treatment of Metastatic Urothelial Carcinoma

The Annals of pharmacotherapy, 2018-01, Vol.52 (1), p.60-68

2018

Volltextzugriff (PDF)

Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans

Journal of the National Medical Association, 2023-04, Vol.115 (2), p.164-174

2023

Volltextzugriff (PDF)

Pharmacy Student Performance in a Capstone Course Utilizing the Pharmacists’ Patient Care Process

American journal of pharmaceutical education, 2019-10, Vol.83 (8), p.7357-1831, Article 7357

2019

Volltextzugriff (PDF)

The Importance of Research and Scholarly Activity in Pharmacy Training

Pharmacotherapy, 2016-12, Vol.36 (12), p.e200-e205

2016

Volltextzugriff (PDF)

National Survey on the Effect of Oncology Drug Shortages in Clinical Practice: A Hematology Oncology Pharmacy Association Survey

JCO oncology practice, 2022-08, Vol.18 (8), p.OP2100883-e1296

2022

Volltextzugriff (PDF)

Getting Your Ducks in a Row: The Case for More Inclusive Renegotiations in EU–Poultry Meat (China)

World trade review, 2019-04, Vol.18 (2), p.309-326

2019

Volltextzugriff (PDF)

Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo

Oncotarget, 2014-02, Vol.5 (3), p.775-787

2014

Volltextzugriff (PDF)

Implementation of a pharmacogenetic panel‐based test for pharmacotherapy‐based supportive care in an adult oncology clinic

Clinical and translational science, 2024-07, Vol.17 (7), p.e13890-n/a

2024

Volltextzugriff (PDF)

Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting

Pharmacotherapy, 2016-02, Vol.36 (2), p.218-229

2016

Volltextzugriff (PDF)

Adverse Cardiovascular Events Associated With Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Metastatic Breast Cancer

Journal of the American Heart Association, 2023-06, Vol.12 (12), p.e029361-e029361

2023

Volltextzugriff (PDF)

Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence

Clinical science (1979), 2011-04, Vol.120 (8), p.307-319

2011

Volltextzugriff (PDF)

A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma

Future oncology (London, England), 2023-09, Vol.19 (27), p.1841-1853

2023

Volltextzugriff (PDF)

Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors

Journal of oncology pharmacy practice, 2020-04, Vol.26 (3), p.647-654

2020

Volltextzugriff (PDF)

Brentuximab vedotin: An anti-CD30 antibody–drug conjugate

American journal of health-system pharmacy, 2013-04, Vol.70 (7), p.589-597

2013

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(96)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(121)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(57)
Science & Technology
(57)
Humans
(35)
Oncology
(24)
Pharmacology & Pharmacy
(24)
Male
(17)
Female
(15)
Animals
(14)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Middle Aged
(11)
Adult
(10)
Chemotherapy
(9)
Aged
(8)
Pharmacology. Drug Treatments
(8)
Social Sciences
(8)
Antineoplastic Agents - Therapeutic Use
(7)
Drug Therapy
(7)
Hematology
(7)
Antineoplastic Agents
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mountains of evidence: The effects of abnormal air pollution on crime

Capivasertib: A Novel AKT Inhibitor Approved for Hormone-Receptor-Positive, HER-2-Negative Metastatic Breast Cancer

Antiangiogenic Therapy for Cancer: An Update

Nilotinib: A second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia

Lack of adequate pneumococcal vaccination response in chronic lymphocytic leukaemia patients receiving ibrutinib

Evaluating Treatment Options and the Multidisciplinary Care of Ocular Toxicities of MEK Inhibitors

Tyrosine kinase inhibitors in the treatment of systemic mastocytosis

Suspiciously timed trade disputes

Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies

Emergence of ocular toxicities associated with novel anticancer therapeutics: What the oncologist needs to know

Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline-Based Chemotherapy

The Emerging Role of PD-1/PD-L1–Targeting Immunotherapy in the Treatment of Metastatic Urothelial Carcinoma

Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans

Pharmacy Student Performance in a Capstone Course Utilizing the Pharmacists’ Patient Care Process

The Importance of Research and Scholarly Activity in Pharmacy Training

National Survey on the Effect of Oncology Drug Shortages in Clinical Practice: A Hematology Oncology Pharmacy Association Survey

Getting Your Ducks in a Row: The Case for More Inclusive Renegotiations in EU–Poultry Meat (China)

Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo

Implementation of a pharmacogenetic panel‐based test for pharmacotherapy‐based supportive care in an adult oncology clinic

Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting

Adverse Cardiovascular Events Associated With Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Metastatic Breast Cancer

Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence

A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma

Immune-mediated adverse events following influenza vaccine in cancer patients receiving immune checkpoint inhibitors

Brentuximab vedotin: An anti-CD30 antibody–drug conjugate

Suchergebnisse filtern